Photo of the Perelman Center for Advanced Medicine
Penn Joins NCCN

The Abramson Cancer Center is honored to be accepted as a member of the National Cancer Center Network (NCCN), an alliance of the top academic cancer centers in the US.

clincal trail
New FDA-Approved Drug for Leukemia
After being tested at Penn, the FDA has approved the first-ever inhibitor drug for AML patients.
Brain Tumor
Battling Brain Cancer

A new immunotherapy developed at Penn may be the world’s best hope against the world’s most aggressive cancer: glioblastoma.

US News and World Report Badge
Top Cancer Hospital in the Nation

We are ranked #1 in the Philadelphia region and 10th in the nation for cancer care by U.S. News & World Report.

Is CAR-T Right For Me?

CAR-T cell therapy was recently approved by the FDA to treat young adults with acute lymphocytic leukemia and adults with non-Hodgkin lymphoma. There are also clinical trials available for all different types of cancer. 

Whether you are newly diagnosed with cancer or looking for a second opinion, request a call back and find out if CAR-T is right for you.